PFANSTIEL STEVEN (CFO) sold 5.4% of their position (2.80K shares) of MARINUS PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $26.7K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 8/8/2023ACC: 0001415889-23-011950
Officer· CFO
Since Apr 2021
-2.80K
Net shares
Net seller
$26.7K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
2.80K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−2.79K
Price / share
$9.54
Trade value
$26.62K
% of position
5.4%
8/7/2023
52.13K→49.34K
Common Stock
Direct
Shares
−14.00
Price / share
$8.93
Trade value
$125.02
% of position
0.0%
8/8/2023
49.34K→49.32K
Total
Net shares
−2.80K
Net value
-$26.74K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/7/2023 | S · Sale | −2.79K | $9.54 | $26.62K | 5.4% | 52.13K | 49.34K |
| Common Stock Direct | 8/8/2023 | S · Sale | −14.00 | $8.93 | $125.02 | 0.0% | 49.34K | 49.32K |
| Total | −2.80K | -$26.74K | ||||||
Derivative Transactions0
No derivative transactions reported